Evaluation of a glycoengineered monoclonal antibody via LC-MS analysis in combination with multiple enzymatic digestion

Reference

• Beck A, Sanglier-Cianferani S, Van Dorsselaer A. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. Anal Chem 2012; 84:4637-46; PMID:22510259; http://dx.doi.org/10.1021/ac3002885
   PubMed Web of Science ®Google Scholar
• Li C, Rossomando A, Wu SL, Karger BL. Comparability analysis of anti-CD20 commercial (rituximab) and RNAi-mediated fucosylated antibodies by two LC-MS approaches. MAbs 2013; 5:565-75; PMID:23751726; http://dx.doi.org/10.4161/mabs.24814
   PubMed Web of Science ®Google Scholar
• Cox KM, Sterling JD, Regan JT, Gasdaska JR, Frantz KK, Peele CG, Black A, Passmore D, Moldovan-Loomis C, Srinivasan M, et al. Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor. Nat Biotechnol 2006; 24:1591-7; PMID:17128273; http://dx.doi.org/10.1038/nbt1260
   PubMed Web of Science ®Google Scholar
• Chen X, Liu YD, Flynn GC. The effect of Fc glycan forms on human IgG2 antibody clearance in humans. Glycobiology 2009; 19:240-9; PMID:18974198; http://dx.doi.org/10.1093/glycob/cwn120
   PubMed Web of Science ®Google Scholar
• Fischer B, Mitterer A, Dorner F, Eibl J. Comparison of N-Glycan pattern of recombinant human coagulation factors II and IX expressed in Chinese Hamster Ovary (CHO) and African Green Monkey (Vero) Cells. J Thromb Thrombolysis 1996; 3:57-62; PMID:10608038
   PubMedGoogle Scholar
• Jez J, Antes B, Castilho A, Kainer M, Wiederkum S, Grass J, Ruker F, Woisetschlager M, Steinkellner H. Significant impact of single N-glycan residues on the biological activity of Fc-based antibody-like fragments. J Biol Chem 2012; 287:24313-9; PMID:22589538; http://dx.doi.org/10.1074/jbc.M112.360701
   PubMed Web of Science ®Google Scholar
• Atmanene C, Wagner-Rousset E, Malissard M, Chol B, Robert A, Corvaia N, Van Dorsselaer A, Beck A, Sanglier-Cianferani S. Extending mass spectrometry contribution to therapeutic monoclonal antibody lead optimization: characterization of immune complexes using noncovalent ESI-MS. Anal Chem 2009; 81:6364-73; PMID:19588976; http://dx.doi.org/10.1021/ac9007557
   PubMed Web of Science ®Google Scholar
• Lu Y, Westland K, Ma YH, Gadgil H. Evaluation of effects of Fc domain high-mannose glycan on antibody stability. J Pharm Sci 2012; 101:4107-17; PMID:22927056; http://dx.doi.org/10.1002/jps.23284
   PubMed Web of Science ®Google Scholar
• Ratner M. Genentech's glyco-engineered antibody to succeed Rituxan. Nat Biotechnol 2014; 32:6-7; PMID:24406911; http://dx.doi.org/10.1038/nbt0114-6b
   PubMed Web of Science ®Google Scholar
• Baker KN, Rendall MH, Hills AE, Hoare M, Freedman RB, James DC. Metabolic control of recombinant protein N-glycan processing in NS0 and CHO cells. Biotechnol Bioeng 2001; 73:188-202; PMID:11257601; http://dx.doi.org/10.1002/bit.1051
   PubMed Web of Science ®Google Scholar
• Nallet S, Fornelli L, Schmitt S, Parra J, Baldi L, Tsybin YO, Wurm FM. Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E cells. N Biotechnol 2012; 29:471-6; PMID:22401955; http://dx.doi.org/10.1016/j.nbt.2012.02.003
   PubMed Web of Science ®Google Scholar
• Oliveira JE, Damiani R, Vorauer-Uhl K, Bartolini P, Ribela MT. Influence of a reduced CO2 environment on the secretion yield, potency and N-glycan structures of recombinant thyrotropin from CHO cells. Mol Biotechnol 2008; 39:159-66; PMID:18327556; http://dx.doi.org/10.1007/s12033-008-9047-6
   PubMed Web of Science ®Google Scholar
• Shi WX, Chammas R, Varki A. Linkage-specific action of endogenous sialic acid O-acetyltransferase in Chinese hamster ovary cells. J Biol Chem 1996; 271:15130-8; PMID:8662976; http://dx.doi.org/10.1074/jbc.271.25.15130
   PubMed Web of Science ®Google Scholar
• Varki A, Gagneux P. Human-specific evolution of sialic acid targets: explaining the malignant malaria mystery? Proc Natl Acad Sci U S A 2009; 106:14739-40; PMID:19717444; http://dx.doi.org/10.1073/pnas.0908196106
   PubMed Web of Science ®Google Scholar
• Baum LG, Derbin K, Perillo NL, Wu T, Pang M, Uittenbogaart C. Characterization of terminal sialic acid linkages on human thymocytes. Correlation between lectin-binding phenotype and sialyltransferase expression. J Biol Chem 1996; 271:10793-9; PMID:8631891; http://dx.doi.org/10.1074/jbc.271.18.10793
   PubMed Web of Science ®Google Scholar
• Bayry J, Bansal K, Kazatchkine MD, Kaveri SV. DC-SIGN and alpha2,6-sialylated IgG Fc interaction is dispensable for the anti-inflammatory activity of IVIg on human dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 2009; 106:E24; author reply E5; PMID:19237553; http://dx.doi.org/10.1073/pnas.0900016106
   PubMed Web of Science ®Google Scholar
• Fukushima K, Takahashi T, Ito S, Takaguchi M, Takano M, Kurebayashi Y, Oishi K, Minami A, Kato T, Park EY, et al. Terminal sialic acid linkages determine different cell infectivities of human parainfluenza virus type 1 and type 3. Virology 2014; 464-465:424-31; PMID:25146600
   PubMed Web of Science ®Google Scholar
• Hatakeyama S, Sakai-Tagawa Y, Kiso M, Goto H, Kawakami C, Mitamura K, Sugaya N, Suzuki Y, Kawaoka Y. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 2005; 43:4139-46; PMID:16081961; http://dx.doi.org/10.1128/JCM.43.8.4139-4146.2005
   PubMed Web of Science ®Google Scholar
• Tanaka K, Mikami M, Aoki D, Kiguchi K, Ishiwata I, Iwamori M. Expression of alpha2,6-sialic acid-containing and Lewis-active glycolipids in several types of human ovarian carcinomas. Oncol Lett 2010; 1:1061-6; PMID:22870113
   PubMed Web of Science ®Google Scholar
• Anthony RM, Nimmerjahn F, Ashline DJ, Reinhold VN, Paulson JC, Ravetch JV. Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc. Science 2008; 320:373-6; PMID:18420934; http://dx.doi.org/10.1126/science.1154315
   PubMed Web of Science ®Google Scholar
• Raymond C, Robotham A, Spearman M, Butler M, Kelly J, Durocher Y. Production of alpha2,6-sialylated IgG1 in CHO cells. MAbs 2015; 7:571-83; PMID:25875452; http://dx.doi.org/10.1080/19420862.2015.1029215
   PubMed Web of Science ®Google Scholar
• Zou G, Ochiai H, Huang W, Yang Q, Li C, Wang LX. Chemoenzymatic synthesis and Fcgamma receptor binding of homogeneous glycoforms of antibody Fc domain. Presence of a bisecting sugar moiety enhances the affinity of Fc to FcgammaIIIa receptor. J Am Chem Soc 2011; 133:18975-91; PMID:22004528; http://dx.doi.org/10.1021/ja208390n
   PubMed Web of Science ®Google Scholar
• Huang W, Giddens J, Fan SQ, Toonstra C, Wang LX. Chemoenzymatic glycoengineering of intact IgG antibodies for gain of functions. J Am Chem Soc 2012; 134:12308-18; PMID:22747414; http://dx.doi.org/10.1021/ja3051266
   PubMed Web of Science ®Google Scholar
• Wei Y, Li C, Huang W, Li B, Strome S, Wang LX. Glycoengineering of human IgG1-Fc through combined yeast expression and in vitro chemoenzymatic glycosylation. Biochemistry 2008; 47:10294-304; PMID:18771295; http://dx.doi.org/10.1021/bi800874y
   PubMed Web of Science ®Google Scholar
• Wang LX, Lomino JV. Emerging technologies for making glycan-defined glycoproteins. ACS Chem Biol 2012; 7:110-22; PMID:22141574; http://dx.doi.org/10.1021/cb200429n
   PubMed Web of Science ®Google Scholar
• Washburn N, Schwab I, Ortiz D, Bhatnagar N, Lansing JC, Medeiros A, Tyler S, Mekala D, Cochran E, Sarvaiya H, et al. Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity. Proc Natl Acad Sci U S A 2015; 112:E1297-306; PMID:25733881; http://dx.doi.org/10.1073/pnas.1422481112
   PubMed Web of Science ®Google Scholar
• Harvey DJ. N-(2-diethylamino)ethyl-4-aminobenzamide derivative for high sensitivity mass spectrometric detection and structure determination of N-linked carbohydrates. Rapid Commun Mass Spectrom: RCM 2000; 14:862-71; PMID:10825250; http://dx.doi.org/10.1002/(SICI)1097-0231(20000530)14:10<862::AID-RCM957>3.0.CO;2-2
   PubMed Web of Science ®Google Scholar
• Klapoetke S, Zhang J, Becht S, Gu X, Ding X. The evaluation of a novel approach for the profiling and identification of N-linked glycan with a procainamide tag by HPLC with fluorescent and mass spectrometric detection. J Pharm Biomed Anal 2010; 53:315-24; PMID:20418045; http://dx.doi.org/10.1016/j.jpba.2010.03.045
   PubMed Web of Science ®Google Scholar
• Sjogren J, Cosgrave EF, Allhorn M, Nordgren M, Bjork S, Olsson F, Fredriksson S, Collin M. Endo S and Endo S2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans. Glycobiology 2015; 25:1053-63; PMID:26156869
   PubMed Web of Science ®Google Scholar
• Ni W, Lin M, Salinas P, Savickas P, Wu SL, Karger BL. Complete mapping of a cystine knot and nested disulfides of recombinant human arylsulfatase A by multi-enzyme digestion and LC-MS analysis using CID and ETD. J Am Soc Mass Spectrom 2013; 24:125-33; PMID:23208745; http://dx.doi.org/10.1007/s13361-012-0510-z
   PubMed Web of Science ®Google Scholar
• Wang Y, Lu Q, Wu SL, Karger BL, Hancock WS. Characterization and comparison of disulfide linkages and scrambling patterns in therapeutic monoclonal antibodies: using LC-MS with electron transfer dissociation. Anal Chem 2011; 83:3133-40; PMID:21428412; http://dx.doi.org/10.1021/ac200128d
   PubMed Web of Science ®Google Scholar
• Xie H, Chakraborty A, Ahn J, Yu YQ, Dakshinamoorthy DP, Gilar M, Chen W, Skilton SJ, Mazzeo JR. Rapid comparison of a candidate biosimilar to an innovator monoclonal antibody with advanced liquid chromatography and mass spectrometry technologies. MAbs 2010; 2:379-94; PMID:20458189; http://dx.doi.org/10.4161/mabs.11986
   PubMed Web of Science ®Google Scholar
• Vlasak J, Bussat MC, Wang S, Wagner-Rousset E, Schaefer M, Klinguer-Hamour C, Kirchmeier M, Corvaia N, Ionescu R, Beck A. Identification and characterization of asparagine deamidation in the light chain CDR1 of a humanized IgG1 antibody. Anal Biochem 2009; 392:145-54; PMID:19497295; http://dx.doi.org/10.1016/j.ab.2009.05.043
   PubMed Web of Science ®Google Scholar
• Ren D, Pipes GD, Liu D, Shih LY, Nichols AC, Treuheit MJ, Brems DN, Bondarenko PV. An improved trypsin digestion method minimizes digestion-induced modifications on proteins. Anal Biochem 2009; 392:12-21; PMID:19457431; http://dx.doi.org/10.1016/j.ab.2009.05.018
   PubMed Web of Science ®Google Scholar
• Zhong X, Kieras E, Sousa E, D'Antona A, Baber JC, He T, Desharnais J, Wood L, Luxenberg D, Stahl M, et al. Pyroglutamate and O-linked glycan determine functional production of anti-IL17A and anti-IL22 peptide-antibody bispecific genetic fusions. J Biol Chem 2013; 288:1409-19; PMID:23184956; http://dx.doi.org/10.1074/jbc.M112.417717
   PubMed Web of Science ®Google Scholar